Certified Advisory Corp’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
WBG
HCIA
Certified Advisory Corp's XPH Position: Q4 2018 in Review
Certified Advisory Corp sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2018, closing a stake of 245 shares — an estimated $12K sold.
Certified Advisory Corp first reported a position in XPH in Q3 2018 and held it in 1 quarter. The position peaked at $12K in Q3 2018. 74 funds tracked by Wall St. Rank hold XPH as of Q4 2018.
- Certified Advisory Corp reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2018 after selling out during the quarter.
- Certified Advisory Corp sold 245 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2018, an estimated $12K.
- Certified Advisory Corp first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and held it in 1 quarter.
- Certified Advisory Corp's State Street SPDR S&P Pharmaceuticals ETF position peaked at $12K in Q3 2018.
- 74 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2018.
Based on Certified Advisory Corp's 13F filing for Q4 2018, filed 4 Feb 2019.